BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
3014 results:

  • 1. Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
    Symons R; Heath F; Duggan J; Bui KT; Byun L; Friedlander M; Lee YC
    Support Care Cancer; 2024 Apr; 32(5):292. PubMed ID: 38632132
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-cancer effects of alpha lipoic acid, cisplatin and paclitaxel combination in the OVCAR-3 ovarian adenocarcinoma cell line.
    Çoban HŞ; Çil N; Önder E; Abban Mete G
    Mol Biol Rep; 2024 Apr; 51(1):485. PubMed ID: 38578399
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Survival Analysis of Patients with Recurrent Epithelial ovarian cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia.
    Harutyunyan L; Manvelyan E; Karapetyan N; Bardakhchyan S; Jilavyan A; Tamamyan G; Avagyan A; Safaryan L; Zohrabyan D; Movsisyan N; Avinyan A; Galoyan A; Sargsyan M; Harutyunyan M; Nersoyan H; Stepanyan A; Galstyan A; Danielyan S; Muradyan A; Jilavyan G
    Curr Oncol; 2024 Mar; 31(3):1323-1334. PubMed ID: 38534933
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro.
    Shariat Razavi SA; Taghdisi Khaboushan M; Jafari R; Shahini A; Ferns GA; Bahrami A
    Physiol Rep; 2024 Mar; 12(6):e15984. PubMed ID: 38531560
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
    Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
    Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Global, regional, and national burden of non-communicable diseases attributable to occupational asbestos exposure 1990-2019 and prediction to 2035: worsening or improving?
    Miao X; Yao T; Dong C; Chen Z; Wei W; Shi Z; Xu T; Shao J; Niu Q; Rui D; Hu Y; Yan Y
    BMC Public Health; 2024 Mar; 24(1):832. PubMed ID: 38500093
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Laparoscopically confirmed endometriosis and anti-Müllerian hormone levels: Findings from the Nurses' Health Study II.
    Farland LV; Valenti M; Degnan WJ; Bertone-Johnson ER; Harris HR; DiVasta AD; Rexrode KM; Eliassen AH; Missmer SA
    Maturitas; 2024 May; 183():107969. PubMed ID: 38489917
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
    Kenney RT; Cini JK; Dexter S; DaFonseca M; Bingham J; Kuan I; Chawla SP; Polasek TM; Lickliter J; Ryan PJ
    Front Immunol; 2024; 15():1362775. PubMed ID: 38487528
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. HER2-low and Overexpression in Mucinous ovarian cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
    Han R; Madariaga A; Gonzalez-Ochoa E; Smith AC; Wang L; Lheureux S; Rouzbahman M
    Int J Gynecol Pathol; 2024 May; 43(3):275-283. PubMed ID: 38436360
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of CD44 and CD24 Expression on 2-years Disease Free Survival in Patients with Advanced Epithelial ovarian Carcinoma.
    Feharsal Y; Andrijono A; Singoprawiro CS; Lisnawati L; Pakasi TA; Putra AD; Kusuma F; Anggraeni TD; Erlina E; Sarwanti S; Mardhiyah T
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):513-519. PubMed ID: 38415537
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Serum miRNA Profiles by Race, Ethnicity, and Socioeconomic Status: Implications for Developing an Equitable ovarian cancer Screening Test.
    Alimena S; Stephenson BJK; Webber JW; Wollborn L; Sussman CB; Packard DG; Williams M; Comrie CE; Wang JY; Markert T; Spiegel J; Rodriguez CB; Lightfoot M; Graye A; O'Connor S; Elias KM
    Cancer Prev Res (Phila); 2024 Apr; 17(4):177-185. PubMed ID: 38388186
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
    Arai H; Yang Y; Baca Y; Millstein J; Denda T; Ou FS; Innocenti F; Takeda H; Kubota Y; Doi A; Horie Y; Umemoto K; Izawa N; Wang J; Battaglin F; Jayachandran P; Algaze S; Soni S; Zhang W; Goldberg RM; Hall MJ; Scott AJ; Hwang JJ; Lou E; Weinberg BA; Marshall J; Goel S; Xiu J; Michael Korn W; Venook AP; Sunakawa Y; Lenz HJ
    Eur J Cancer; 2024 Apr; 201():113914. PubMed ID: 38359495
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO.
    Murphy G; Freedman ND; Abnet CC; Albanes D; Cross AJ; Huang WY; Koshiol J; McGlynn K; Parisi D; Männistö S; Weinstein SJ; Waterboer T; Butt J
    Helicobacter; 2024; 29(1):e13053. PubMed ID: 38332674
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition.
    Montalvo MJ; Bandey IN; Rezvan A; Wu KL; Saeedi A; Kulkarni R; Li Y; An X; Sefat KMSR; Varadarajan N
    Cell Death Dis; 2024 Feb; 15(2):109. PubMed ID: 38307835
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Acetogenins from the Stem of
    Gurgul A; Khin M; Souliya O; Sydara K; Burdette JE; Johnson JJ; Che CT
    J Nat Prod; 2024 Feb; 87(2):207-216. PubMed ID: 38237151
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prenatal Counseling on the Maternal Health Benefits of Lactation: A Randomized Trial.
    Schwarz EB; Hoyt-Austin A; Fix M; Kair LR; Iwuagwu C; Chen MJ
    Breastfeed Med; 2024 Jan; 19(1):52-58. PubMed ID: 38190278
    [No Abstract]    [Full Text] [Related]  

  • 17. Air quality and cancer risk in the All of Us Research Program.
    Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
    Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of Cold Ischemia on the Stability of
    Ricci A; Dugo M; Pisanu ME; De Cecco L; Raspagliesi F; Valeri B; Veneroni S; Chirico M; Palombelli G; Daidone MG; Podo F; Canese R; Mezzanzanica D; Bagnoli M; Iorio E
    J Proteome Res; 2024 Jan; 23(1):483-493. PubMed ID: 38109371
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Associations between Two Dietary Quality Scores and Pancreatic cancer Risk in a US National Prospective Cohort Study.
    Hoyt M; Song Y; Gao S; O'Palka J; Zhang J
    J Am Nutr Assoc; 2024; 43(4):345-355. PubMed ID: 38096044
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 151.